Skip to main content
-
adenocarcinoma
-
cancer development arising from the glandular tissues that line body organs
-
alopecia
-
abnormal loss of body hair
-
benign
-
not causing harmful effects
-
chemotherapy
-
drug therapy focused on killing cancer cells
-
embolization
-
the introduction of a foreign object (bone fragments, cells, air, blood clot) into the bloodstream
-
erythrocytes
-
a red blood cell
-
erythrocytopenia
-
a decrease below normal levels of circulating erythrocytes
-
extravasate
-
the leakage of a vesicant drug into the tissues surrounding the intravenous infusion site
-
febrile neutropenia
-
occurrence of a fever during a period of neutropenia, when the risk of infection is higher than normal
-
fibrosis
-
the thickening or scarring of connective tissue
-
granulocytes
-
a white blood cell type; assists in fighting invading organisms
-
granulocytopenia
-
a decrease below normal levels of circulating granulocytes
-
hematological cancers
-
cancer development arising from bone marrow cells
-
hemorrhagic cystitis
-
inflammation of the bladder lining, resulting in bleeding and hematuria
-
leukemia
-
cancer development arising from leukocytes
-
leukocytes
-
a white blood cell type; assists in fighting invading organisms
-
leukopenia
-
a decrease below normal levels of circulating leukocytes
-
mesna
-
a medicine used to prevent hemorrhagic cystitis in clients receiving chemotherapy
-
metastasize
-
spread to other sites in the body
-
mucositis
-
inflammation and ulceration of oral and/or gastrointestinal mucous membranes; often a side effect of chemotherapy or radiation therapy
-
multiple myeloma
-
cancer development arising from plasma cells
-
mutation
-
a change in the nucleic acid sequence in a cell
-
myelosuppression
-
decreased production of blood cells by the stem cells in the bone marrow
-
nadir
-
the point after a chemotherapy treatment at which a client’s blood cell counts are at the lowest level before recovery
-
neoangiogenesis
-
the ability of a tumor mass to grow new vascularity
-
neutropenia
-
a decrease below normal levels of circulating neutrophils
-
neutrophils
-
a white blood cell type; assists in fighting invading organisms
-
non-Hodgkin lymphoma
-
cancer development arising from lymph cells
-
oncogene
-
a mutated gene that has the potential to cause cancer development
-
pancytopenia
-
a decrease below normal levels of all circulation blood cell lines including white blood cells, red blood cells, and platelets
-
plant alkaloid
-
naturally occurring organic nitrogen-containing bases derived from plants
-
pulmonary toxicity
-
lung damage
-
secondary cancer
-
a cancer that develops after exposure to treatment for a previous cancer
-
squamous cell carcinoma
-
cancer development arising from skin cells
-
thrombocytes
-
a platelet: a cell that helps to form blood clots
-
thrombocytopenia
-
a decrease below normal levels of circulating thrombocytes
-
tumor lysis syndrome
-
a condition occurring after administration of chemotherapy resulting in cell death that releases cellular contents into the blood
-
vesicant
-
any intravenous drug capable of causing blistering and tissue damage should extravasation occur